As I mentioned previously I purchased VXX. It had gone up a few dollars per share and then stagnated. I placed a stop limit order because I was greedy and wanted to keep from losing to much if the price plummeted.
I placed the order so that if the price dropped below $31.15 the stock would be sold automatically as long as the price at the time it was sold was higher than $31.00 per share. I did not want to lose too much if the stock price dropped drastically.
On February 28, 2011 VXX closed at $30.18 per share but my shares were not sold. The price dropped $1.33 from the close the previous business day. What happened? The opening bid and sale on February 28th was below $31.00 per share and never rose above $31.00 per share so my stop limit order was never triggered.
Monday, February 28, 2011
Tuesday, February 22, 2011
VXX shares are the highpoint of a low day.
I am a little behind in my posts. I made the following two transactions:
Purchased MOTR July 2011 $12.50 call options and also purchased VXX shares.
After the market downturn today I wish I had purchased more VXX shares. The VXX shares were the only shares that went up in my portfolio.
Purchased MOTR July 2011 $12.50 call options and also purchased VXX shares.
After the market downturn today I wish I had purchased more VXX shares. The VXX shares were the only shares that went up in my portfolio.
Monday, February 14, 2011
Fortescue Metals Group - a long-term hold
FSUMF as a long-term commodity play.
The information below was found at http://www.bloomberg.com/news/2010-10-14/fortescue-metals-reports-first-quarter-iron-ore-shipments-increased-7-7-.html
Fortescue said this week it had agreed a $2.04 billion loan to refinance debt in order to pursue expansions. Production will continue to operate at an annual rate of 40 million tons until February, when it will rise to 55 million tons, the company said.
The shipments beat company guidance “despite a number of scheduled major maintenance” shutdowns at the company’s port and the mine, Fortescue said in a statement. “Fortescue continued to diversify its customer base with three shipments made to new customers in Japan and Australia.”
The company has outlined plans to expand production to 155 million tons by fiscal 2014 through development of the Solomon and Western Hub projects, as well as a longer-term expansion to 355 million tons.
The information below was found at http://www.bloomberg.com/news/2010-10-14/fortescue-metals-reports-first-quarter-iron-ore-shipments-increased-7-7-.html
Fortescue said this week it had agreed a $2.04 billion loan to refinance debt in order to pursue expansions. Production will continue to operate at an annual rate of 40 million tons until February, when it will rise to 55 million tons, the company said.
The shipments beat company guidance “despite a number of scheduled major maintenance” shutdowns at the company’s port and the mine, Fortescue said in a statement. “Fortescue continued to diversify its customer base with three shipments made to new customers in Japan and Australia.”
The company has outlined plans to expand production to 155 million tons by fiscal 2014 through development of the Solomon and Western Hub projects, as well as a longer-term expansion to 355 million tons.
Neoprobe's Lymphoseek
Today on Bloomberg radio's "Taking Stock" a drug called Lymphoseek was discussed. The drug is currently in Phase 3 trials. I have not purchased this stock but am investigating further.
One article I found at medcitynews.com (http://www.medcitynews.com/2010/04/neoprobe-to-file-for-fda-approval-of-lymphoseek-this-summer/) contains the following information:
"The company has said that within two years of Lymphoseek’s release it would have more than half the market share, thanks to its agreement with Cardinal Health to distribute the drug once it’s ready."
One article I found at medcitynews.com (http://www.medcitynews.com/2010/04/neoprobe-to-file-for-fda-approval-of-lymphoseek-this-summer/) contains the following information:
"The company has said that within two years of Lymphoseek’s release it would have more than half the market share, thanks to its agreement with Cardinal Health to distribute the drug once it’s ready."
Thursday, February 10, 2011
Runners take your positions.
The information below reflects my holdings as of February 11, 2011. When I remember I may put the purchase date in parentheses after the stock symbol. Note: The MOTR calls are my first ever purchase of call options and the VXX purchase is my first involving volatility indexes. The VXX purchase was a gut purchase without a lot of research; hopefully not a punch in the gut.
* = stock pays a dividend.
ACTC (11/12/2009, 11/13/2009, 11/18/2009, 12/21/2009, 2/22/2010, 2/23/2010, 4/15/2010, 5/3/2010, 5/5/2010, 8/5/2010, 9/2/2010)
CADX (10/20/2010, 11/2/2010, 11/19/2010)
CIM* (12/10/2009, 9/2/2009, 9/16/2010, 9/21/2010)
DRYS (5/07/2009, 5/08/2009 , 5/11/009, 5/14/2009, 10/28/2009, 11/20/2009)
FLS (10/28/2010)
FSUMF (6/24/2010)
MOTR - July 2011 $12.50 calls (2/9/2011)
PVCT (9/13/2010)
RAX (10/6/2010)
SQNM (8/6/2011 & 1/14/2011)
VXX (2/9/2011)
* = stock pays a dividend.
ACTC (11/12/2009, 11/13/2009, 11/18/2009, 12/21/2009, 2/22/2010, 2/23/2010, 4/15/2010, 5/3/2010, 5/5/2010, 8/5/2010, 9/2/2010)
CADX (10/20/2010, 11/2/2010, 11/19/2010)
CIM* (12/10/2009, 9/2/2009, 9/16/2010, 9/21/2010)
DRYS (5/07/2009, 5/08/2009 , 5/11/009, 5/14/2009, 10/28/2009, 11/20/2009)
FLS (10/28/2010)
FSUMF (6/24/2010)
MOTR - July 2011 $12.50 calls (2/9/2011)
PVCT (9/13/2010)
RAX (10/6/2010)
SQNM (8/6/2011 & 1/14/2011)
VXX (2/9/2011)
Why I created this blog.
A co-worker and I would informally share information about interesting stocks. It was fun to share little bits of news about companies with nice dividends or those whose stocks might be about to "pop." So this blog is an extension of that sharing. Maybe I should have a disclaimer. O.K. Disclaimer: This blog contains my personal thoughts and opinions. The information in this blog is not intended as advice and should not be used as the basis for purchasing or selling stocks, options or any other investment. I am not responsible for how the information on this blog may be used by others. I have no formal training in the area of finance. Disclaimer over.
I plan to post the names of the stocks that I have in my account and maybe some comments about why I bought or sold them. I would be interested in any comments you have about these stocks or others that you may own or are considering owning. Hence the "share" part of this blog.
I plan to post the names of the stocks that I have in my account and maybe some comments about why I bought or sold them. I would be interested in any comments you have about these stocks or others that you may own or are considering owning. Hence the "share" part of this blog.
Subscribe to:
Posts (Atom)